Picard Medical
18 hedge funds and large institutions have $511K invested in Picard Medical in 2026 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 27 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
3.01% less ownership
Funds ownership: 8.23% → 5.22% (-3%)
55% less funds holding
Funds holding: 40 → 18 (-22)
60% less capital inflows, than outflows
Capital inflows: $227K | Capital outflows: $570K
81% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$91.4K |
| 2 |
Jane Street
New York
|
+$45K |
| 3 |
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
|
+$44.5K |
| 4 |
Morgan Stanley
New York
|
+$19.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$14.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$351K |
| 2 |
IEQ Capital
Foster City,
California
|
-$47.5K |
| 3 |
Renaissance Technologies
New York
|
-$28.2K |
| 4 |
Cerity Partners
New York
|
-$18.9K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.9K |
PMI Hedge Fund Activity: Q3 2026 in Review
18 of the 8,193 institutional investors tracked by Wall St. Rank reported a position in Picard Medical (PMI) for Q3 2026, worth a combined $511K — down 59% from $1.24M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of PMI and 5 opened new positions — a net loss of 22 holders — while 6 trimmed existing stakes and 6 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $91.4K. The largest seller was AQR Capital Management, exiting entirely with an estimated $351K sold.
- 18 institutional investors held Picard Medical (PMI) as of Q3 2026, down from 40 in Q2 2026.
- Funds reported $511K of Picard Medical stock for Q3 2026, down 59% quarter-over-quarter.
- 5 funds opened new Picard Medical positions in Q3 2026 and 27 closed out, a net change of -22 holders.
- The largest Picard Medical buyer in Q3 2026 was Citadel Advisors, an estimated $91.4K added.
- The largest Picard Medical seller in Q3 2026 was AQR Capital Management, an estimated $351K sold.
Based on aggregated 13F filings for Q3 2026.